Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8026247 Bicyclic amides as kinase inhibitors

Patent 8026247 was granted and assigned to Novartis on September, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 5 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
0
Edits on 24 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors
0
Edits on 28 Nov, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 28 Nov, 2023
Edits made to:
Article (+423 characters)
Article

Patent abstract

The invention relates to compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula I and to the use of a compound of formula I for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases.

Edits on 20 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 20 Sep, 2023
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Andrea Vaupel0
Andreas Floersheimer0
Giorgio Caravatti0
Guido Bold0
Hans-Georg Capraro0
Pascal Furet0
Paul W. Manley0
Edits on 14 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 14 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08026247 Bicyclic amides as kinase inhibitors US Patent 8026247 Bicyclic amides as kinase inhibitors

Infobox
Patent Number
080262470
Patent Number
80262470
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Novartis
Novartis
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
080262470
Date of Patent
September 27, 2011
0
Patent Application Number
115750250
Date Filed
September 14, 2005
0
Patent Primary Examiner
‌
Kahsay T. Habte
0
Edits on 13 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 13 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08026247 Bicyclic amides as kinase inhibitors

Infobox
Is a
Patent
Patent
Current assignee
Novartis
Novartis
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08026247
Date of patent
September 27, 2011
Patent application number
11575025
Date Filed
September 14, 2005
Patent primary examiner
‌
Kahsay T. Habte

Find more entities like US Patent 8026247 Bicyclic amides as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo